HCM
SANA icon

Hilton Capital Management’s Sana Biotechnology SANA Stock Holding History

Hilton Capital Management’s Portfolio SANA Stock Details SANA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-22,075
Closed -$89.8K – 164
2025
Q4 		$89.8K Sell
22,075
-45,040
-67% -$202K 0.01% 163
2025
Q3 		$238K Buy
+67,115
New +$243K 0.02% 161

Other funds holding SANA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
MG
Marex Group London $23.6B AUM 57.16% 1-Year Est. Return
IHAM
Integral Health Asset Management New York $2.53B AUM 154.61% 1-Year Est. Return

Hilton Capital Management's SANA Position: Q1 2026 in Review

Hilton Capital Management sold out of Sana Biotechnology (SANA) in Q1 2026, closing a stake of 22,075 shares — an estimated $89.8K sold.

Hilton Capital Management first reported a position in SANA in Q3 2025 and held it in 2 quarters. The position peaked at $238K in Q3 2025. 203 funds tracked by Wall St. Rank hold SANA as of Q1 2026.

  • Hilton Capital Management reported no remaining Sana Biotechnology position as of Q1 2026 after selling out during the quarter.
  • Hilton Capital Management sold 22,075 Sana Biotechnology shares in Q1 2026, an estimated $89.8K.
  • Hilton Capital Management first reported a position in Sana Biotechnology in Q3 2025 and held it in 2 quarters.
  • Hilton Capital Management's Sana Biotechnology position peaked at $238K in Q3 2025.
  • 203 funds tracked by Wall St. Rank held Sana Biotechnology as of Q1 2026.

Based on Hilton Capital Management's 13F filing for Q1 2026, filed 15 May 2026.